Novel agents and new therapeutic approaches for treatment of multiple myeloma

doi:10.5662/wjm.v4.i2.73

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

(400)

(319)

(0)

(7873)

(28)

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Methodol. Jun 26, 2014; 4(2): 73-90
Published online Jun 26, 2014. doi: 10.5662/wjm.v4.i2.73

Table 1 Bortezomib-based induction, immunomodulatory-based induction, bortezomib-based and immunomodulatory-based regimens for transplant-elegible patients

Regimen	Drugs	Ref.
Bortezomib-based induction
VD	Bortezomib/dexamethasone	[12,13]
VTD	Bortezomib/thalidomide/dexamethasone	[12,13]
CyBorD or VCD	Bortezomib/cyclophosphamide/dexamethasone	[14-16]
VCRD	Bortezomib/cyclophosphamide/lenalidomide/dexamethasone	[14-16]
VRD	Bortezomib/lenalidomide/dexamethasone	[14-16]
Immunomodulatory-based induction
TD	Thalidomide/dexamethasone	[19,20]
VTD	Bortezomib/thalidomide/dexamethasone	[12,13]
Rd	Lenalidomide/low-dose dexamethasone	[23]
VCRD	Bortezomib/cyclophosphamide/lenalidomide/dexamethasone	[14-16]
VRD	Bortezomib/lenalidomide/dexamethasone	[14-16]
Bortezomib-based
VMP	Bortezomib/melphalan/prednisone	[29-31]
VMPT	Bortezomib/melphalan/prednisone/thalidomide	[30]
Immunomodulatory-based
TD	Thalidomide/dexamethasone	[32]
MPT	Melphalan/prednisone/thalidomide	[40,41]
Rd	Lenalidomide/low-dose dexamethasone	[44]
RD	Lenalidomide/high-dose dexamethasone	[43]
MPR	Melphalan/prednisone/lenalidomide	[45]

Full Size Table

Citation: Ria R, Reale A, Vacca A. Novel agents and new therapeutic approaches for treatment of multiple myeloma. World J Methodol 2014; 4(2): 73-90
URL: https://www.wjgnet.com/2222-0682/full/v4/i2/73.htm
DOI: https://dx.doi.org/10.5662/wjm.v4.i2.73

Ria R, Reale A, Vacca A. Novel agents and new therapeutic approaches for treatment of multiple myeloma. World J Methodol 2014; 4(2): 73-90 [PMID: 25332907 DOI: 10.5662/wjm.v4.i2.73]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.